The effect of the extract of Crocus sativus and its constituent safranal, on lung pathology and lung inflammation of ovalbumin sensitized guinea-pigs - PubMed
- ️Sun Jan 01 2012
. 2012 Jul 15;19(10):904-11.
doi: 10.1016/j.phymed.2012.05.006. Epub 2012 Jun 27.
Affiliations
- PMID: 22743244
- DOI: 10.1016/j.phymed.2012.05.006
The effect of the extract of Crocus sativus and its constituent safranal, on lung pathology and lung inflammation of ovalbumin sensitized guinea-pigs
M H Boskabady et al. Phytomedicine. 2012.
Abstract
Different pharmacological effects of Crocus sativus have been demonstrated on guinea pig tracheal chains in previous studies. In the present study, the prophylactic effect of the extract of C. sativus and its constituent, safranal on lung pathology and total and differential white blood cells (WBC) of sensitized guinea pigs was examined. Guinea pigs were sensitized with injection and inhalation of ovalbumin (OA). One group of sensitized guinea pigs were given drinking water alone (group S) and three groups were given drinking water containing three concentrations of safranal (S+SA1, S+SA2 and S+SA3 groups), three groups, drinking water containing three concentrations of extract (S+CS1, S+CS2 and S+CS3 groups) and one group drinking water containing one concentration of dexamethasone (S+D group) (n=6, for all groups). The lung pathology was evaluated in control, non treated and treated sensitized groups. Total and differential WBC counts of lung lavage were also examined. All pathological indices in group S showed significant increased compared to control group (p<0.05 for lung congestion and p<0.001 for other groups). Total WBC number (p<0.001), eosinophyl percentage (p<0.001) in lung lavage and serum histamine levels (p<0.01) were also increased in sensitized animals compared to those of controls. Treatment of S animals with dexamethasone, all concentrations of the extract and safranal significantly improved lung pathological changes, most types of WBC and serum histamine levels compared to group S (p<0.05-0.001). Treatment of S group with first concentration of safranal also decreased total WBC. Treatment with safranal was more effective in improvement of most pathological changes, total and differential WBC count as well as serum histamine level (p<0.05-0.001). These results showed a preventive effect of the extract of C. sativus and its constituent safranal on lung inflammation of sensitized guinea pigs. The results also showed that the effect of the plant is perhaps due to its constituent safranal.
Copyright © 2012 Elsevier GmbH. All rights reserved.
Similar articles
-
Stimulatory effect of Crocus sativus (saffron) on beta2-adrenoceptors of guinea pig tracheal chains.
Nemati H, Boskabady MH, Ahmadzadef Vostakolaei H. Nemati H, et al. Phytomedicine. 2008 Dec;15(12):1038-45. doi: 10.1016/j.phymed.2008.07.008. Epub 2008 Sep 3. Phytomedicine. 2008. PMID: 18771905
-
Byrami G, Boskabady MH, Jalali S, Farkhondeh T. Byrami G, et al. J Ethnopharmacol. 2013 May 20;147(2):530-5. doi: 10.1016/j.jep.2013.03.014. Epub 2013 Mar 15. J Ethnopharmacol. 2013. PMID: 23506987
-
Pitsikas N. Pitsikas N. Molecules. 2021 Feb 25;26(5):1237. doi: 10.3390/molecules26051237. Molecules. 2021. PMID: 33669124 Free PMC article. Review.
-
Neuroprotective Potency of Safranal Against Neurological Disorders.
Fazeli E, Ghalibaf MHE, Forouzanfar F. Fazeli E, et al. Curr Mol Med. 2023;23(9):952-959. doi: 10.2174/1566524023666221117104612. Curr Mol Med. 2023. PMID: 36397621 Review.
Cited by
-
Ayoub IM, Korinek M, El-Shazly M, Wetterauer B, El-Beshbishy HA, Hwang TL, Chen BH, Chang FR, Wink M, Singab ANB, Youssef FS. Ayoub IM, et al. Plants (Basel). 2021 May 31;10(6):1118. doi: 10.3390/plants10061118. Plants (Basel). 2021. PMID: 34073129 Free PMC article.
-
Ghobadi H, Aslani F, Boskabady MH, Saadat S, Aslani MR. Ghobadi H, et al. Front Pharmacol. 2024 Sep 4;15:1436295. doi: 10.3389/fphar.2024.1436295. eCollection 2024. Front Pharmacol. 2024. PMID: 39295946 Free PMC article.
-
Butnariu M, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Singh L, Aborehab NM, Bouyahya A, Venditti A, Sen S, Acharya K, Bashiry M, Ezzat SM, Setzer WN, Martorell M, Mileski KS, Bagiu IC, Docea AO, Calina D, Cho WC. Butnariu M, et al. Oxid Med Cell Longev. 2022 Feb 14;2022:8214821. doi: 10.1155/2022/8214821. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35198096 Free PMC article. Review.
-
Neamati A, Chaman F, Hosseini M, Boskabady MH. Neamati A, et al. J Pharm Bioallied Sci. 2014 Apr;6(2):97-103. doi: 10.4103/0975-7406.129174. J Pharm Bioallied Sci. 2014. PMID: 24741277 Free PMC article.
-
Erfanparast A, Tamaddonfard E, Taati M, Dabbaghi M. Erfanparast A, et al. Avicenna J Phytomed. 2015 Sep-Oct;5(5):392-402. Avicenna J Phytomed. 2015. PMID: 26468458 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous